Home › Chronic Myelomonocytic Leukemia › Georgia › Atlanta
Chronic Myelomonocytic Leukemia clinical trials in Atlanta, GA
4 studies for Chronic Myelomonocytic Leukemia are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RecruitingPhase 2
- Winship Cancer Institute - Emory University, Atlanta
Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
RecruitingPhase 2
- Winship Cancer Institute at Emory, Atlanta
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
RecruitingObservational study
- Emory University, Atlanta
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RecruitingPhase 2/3
- University of Emory - Winship Cancer Institute, Atlanta
Chronic Myelomonocytic Leukemia trials in other cities
- Houston, TX16 studies
- Seattle, WA10 studies
- Boston, MA7 studies
- Mountain View, CA6 studies
- Baldwin Park, CA6 studies
- Rochester, MN6 studies
- New York City, NY6 studies
- Durham, NC5 studies
- Miami, FL4 studies
- Tampa, FL4 studies
- Birmingham, AL4 studies
- Columbus, OH4 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer47 studies
- Multiple Myeloma42 studies
- Breast Cancer41 studies
- Prostate Cancer33 studies
- Acute Myeloid Leukemia31 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Lung Cancer29 studies
- Metastatic Cancer28 studies
- Major Depressive Disorder25 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.